Clinical trials & evidence

AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial

Parkinson’s Gets a Cleaner Dopamine Bet

Myasthenia Care Cannot Wait for Crisis

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty

C. Diff Can Hide in Plain Sight.

Radiopharmaceuticals Just Got a Necessary No

Sprint interval training triggered a bigger molecular response than 90 minutes of cycling. Bigger is not yet better

Ovarian Cancer May Finally Have a Way to Drug p53
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
